Xiaoling Che
Overview
Explore the profile of Xiaoling Che including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mao K, Jin H, Mao W, Guo R, Che X
Environ Res
. 2024 Oct;
263(Pt 3):120252.
PMID: 39481787
Recent studies have demonstrated the widespread presence of 1,3-diphenylguanidine (DPG) and its derivatives in environmental matrices. While, the amount of human exposure to these rubber additives remains unclear. In this...
2.
Yang C, Che X, Zhang Y, Gu D, Dai G, Shu J, et al.
Int J Nanomedicine
. 2024 Jan;
18:8023-8037.
PMID: 38164263
Background: Development of versatile nanoplatform still remains a great challenge due to multistep synthesis and complicated compositions. Therefore, it is significant to develop a facile method to synthesize a nanocomposite...
3.
Che X, Yang C, Pan L, Gu D, Dai G, Shu J, et al.
Biomater Res
. 2023 Nov;
27(1):119.
PMID: 37990349
Background: Non-intrusive imaging of gastrointestinal (GI) tract using computed tomography (CT) contrast agents is of the most significant issues in the diagnosis and treatment of GI diseases. Moreover, spectral CT,...
4.
Wang L, Du X, Hu P, Zhang Y, Yao M, Che X
J Cancer Res Clin Oncol
. 2023 Sep;
149(18):16669-16678.
PMID: 37721568
Background: Breast cancer-related lymphedema (BCRL) may benefit from acupuncture as a therapeutic. However, the findings of systematic reviews (SRs) and meta-analyses (MAs) are inconsistent and their quality needs to be...
5.
Wang J, Wang Y, Che X
Medicine (Baltimore)
. 2023 Jan;
102(4):e32644.
PMID: 36705379
Rationale: Pseudoprogression has been deemed as a rare clinical phenomenon during the treatment of immune checkpoint inhibitors in patients with advanced cancers, especially in periampullary carcinoma, however, leaving potential molecular...
6.
Xing B, Dong B, Che X
J Orthop Surg Res
. 2023 Jan;
18(1):43.
PMID: 36647086
Background: Supracondylar humeral fractures (SCHFs) are frequent in children, and closed reduction with percutaneous pin fixation remains the standard surgical treatment for displaced SCHFs. Two pinning configurations, medial-lateral crossed entry...
7.
Tang Y, Che X, Wang W, Su S, Nie Y, Yang C
Med Phys
. 2022 Jul;
49(12):7555-7566.
PMID: 35869750
Background: Breast cancer (BC) is among the most common cancers worldwide. Machine learning-based radiomics model could predict axillary lymph node metastasis (ALNM) of BC accurately. Purpose: The purpose is to...
8.
Zhou J, Zhu Y, Gong C, Liang X, Zhou X, Xu Y, et al.
Nutr Metab (Lond)
. 2019 Jan;
16:5.
PMID: 30651747
Background: The haplotype of the vitamin D binding protein (encoded by the gene) might be a risk factor to the vitamin D (VD) nutritional status for many populations, while evidences...
9.
Chen J, Wang J, Wu X, Che X, Zou Y, Weng M, et al.
Future Oncol
. 2017 Oct;
13(24):2195-2207.
PMID: 28994614
Aim: We performed a meta-analysis to evaluate the efficacy and safety for S-1-based regimens as the first-line treatment in Asian chemotherapy-naive patients with advanced non-small-cell lung cancer. Patients & Methods:...
10.
Zhu Z, Liu Y, Che X, Chen X
Inform Health Soc Care
. 2017 Jan;
43(1):22-41.
PMID: 28068149
Mobile chronic disease management systems (MCDMS) have become increasingly important in recent years, but in China, challenges remain for their adoption. Existing empirical studies have not completely explored the adoption...